CStone Pharmaceuticals (2616.HK) HKSE

6.72

-0.17(-2.47%)

Updated at October 20 10:18AM

Currency In HKD

Valuation

Market Cap2.76B
Enterprise Value2.72B
P/E Ratio-33.59
PEG Ratio-0.34
Price/Sales Ratio51.93
Price/Book Ratio25.8
Enterprise/Revenue51.56
Enterprise/EBITDA-42.31

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-1.36
Operating Margin-1.36

Management Effectiveness

Return On Assets-0.2
Return On Equity-0.71

Income Statement

Revenue407.21M
Revenue/Share0.14
Gross Profit240.15M
EBITDA-76.43M
Net Income-91.21M
Diluted EPS-0.07

Balance Sheet

Total Cash690.1M
Total Cash/Share0.54
Total Debt391.37M
Total Debt/Equity1.24
Current Ratio1.44
Book Value Per Share0.24

Price History

52-Week Change282.78
52-Week High13.15
52-Week Low1.68
Moving Average 50 Days8.95
Moving Average 200 Days4.99

Statistics

Average Volume22.68M
Shares Outstanding1.46B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A